QUOTE AND NEWS
Benzinga  Mar 27  Comment 
Below are the top drug stores services stocks on the NYSE and the NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at GNC Holdings (NYSE: GNC) is 10.08%. GNC's EPS for the same period is $2.72. The...
SeekingAlpha  Mar 19  Comment 
By Johannes Salim: Over past couple of months, GNC Holdings (GNC), a leading specialty retailer of health and wellness products, has come onto my investing radar screen due to more than 20% share price decline from its 52-week high ($60.98/share...
TheStreet.com  Mar 17  Comment 
Update (9:35 a.m.): Updated with Monday market open information. NEW YORK (TheStreet) -- Credit Suisse downgraded GNC Holdings  to "neutral" from "outperform" and set a $51 target price. The firm noted the company has lower sales...
Benzinga  Mar 17  Comment 
Benzinga  Mar 17  Comment 
In a report published Monday, Credit Suisse analyst Gary Balter downgraded the rating on GNC (NYSE: GNC) from Outperform to Neutral, and lowered the price target from $65.00 to $51.00. In the report, Credit Suisse noted, “While we are...
SeekingAlpha  Mar 5  Comment 
By Detroit Bear: The world of sports supplements, vitamins, and herbal remedies has become en vogue over the past decade. Not long ago healthy supplements like protein and creatine were lumped in with the likes of HGH and steroids. Now, the cohort...
TheStreet.com  Mar 4  Comment 
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener. NEW YORK (TheStreet) -- Here are some of the hot stocks Jim Cramer talked about on Monday's Mad Money on CNBC: BIDU data by...
SeekingAlpha  Feb 19  Comment 
By Mike Arnold: Executive summary: The sell-off in GNC Holdings shares appears overdone. $500 million share buyback program designed to return value to shareholders could provide support for shares. International expansion offers new...
Reuters  Feb 18  Comment 
* GNC president says army will defend its legitimacy (Recasts with militia threat, details, background)     
Trading with the Average Jay  Feb 16  Comment 
Closed out with another winning week. 1. Short trades in GNC Holdings Inc (GNC.) This trade was called by Meir in the trading room. I had some difficulties trying to exit the trade as I forgot I still had a limit price in the trade box and it...
SeekingAlpha  Feb 15  Comment 
By Igor Novgorodtsev: (Editors' Note: This article covers a stock trading at less than $1 per share and/or has less than a $100 million market cap. Please be aware of the risks associated with these stocks.) ...




 
TOP CONTRIBUTORS

GNC Holdings, Inc (NYSE:GNC) is a nutritional supplement retailer with more than 7,200 worldwide locations. Each of the company's retail locations sell health and wellness products such as vitamins, minerals, herbal supplements, and diet products. The company sells a large line of products which are sold with the GNC brand name on it.[1]

According to the Nutrition Business Journal, the nutritional supplements industry generated an estimated $28.7B in 2010. It is projected to grow at a Compounded annual growth rate - CAGR of approximately 5.3% until 2015. GNC views the market as being highly fragmented across distributors and producers. GNC believes that this growth and fragmentation provide a significant advantage to a relatively larger operator like GNC.[2]

The company's initial public offering of stock on the NYSE occurred on March 31, 2011. The company offered 22.5M shares each for $16. This was at the midpoint of the $15-$17 initial price range. 6.5M of its 22.5M offered shares were sold by the company's private equity sponsors. This brought the total deal size to $45M. The lead underwriter of the IPO were Goldman Sachs Group (GS), J P Morgan Chase (JPM), Deutsche Bank AG (DB), and Morgan Stanley (MS).[3]

In 2010, GNC reported a total revenue of $1.8B. This was an increase over the 2009 figure of $1.7B. The company's net income in 2010 was $96.6M. This was a 13% decrease from the $111.9 M net income reported for 2009.[4]

References

  1. GNC S-1/A 2011 PROSPECTUS SUMMARY "Our Company" pg 1
  2. GNC S-1/A 2011 PROSPECTUS SUMMARY "Industry Overview" pg 2
  3. Renaissance Capital - IPO Home "Nutritional supplement retailer GNC prices its IPO at $16, within the range" 31 March 2011
  4. GNC S-1/A 2011 PROSPECTUS SUMMARY "Summary Consolidated Financial Data" pg 12-13
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki